GenScript Launches Rush Gene Synthesis Service

Printer-friendly versionPDF version

Internationally recognized biology contract research organization GenScript USA Inc. today announced the launch of Rush Gene Synthesis service in global market.

PISCATAWAY, N.J., United States., December 25, 2011 - (PressReleasePoint) - Internationally recognized biology contract research organization GenScript USA Inc. today announced the launch of Rush Gene Synthesis service in global market.
 
As the largest gene synthesis supplier worldwide, GenScript is dedicated to improve the quality and speed of gene synthesis by developing and applying innovative technologies. With the Rush Gene Synthesis service, GenScript will deliver synthesized genes in as little as 5 business days. The Rush Gene Synthesis service features not only fast delivery and short turnaround time, but also a high quality and affordable service for your projects with pressing needs.
 
Besides the world-leading gene synthesis service, GenScript, as a contract research organization (CRO), also provides comprehensive services for biological research and early-phase drug discovery, such as bio-reagents, assay development & screening, lead optimization, antibody drug development and animal model services. The bio-reagents services include custom gene synthesis and molecular biology, custom protein expression and purification, custom peptide synthesis, antibody production, and custom cell line development. Headquartered in Piscataway, New Jersey, GenScript has three subsidiaries located in France, Japan, and China.
# # # #
For further information, please contact:
Sally Wang
Executive Vice President
GENSCRIPT USA Inc.
1-(732) 885-9188
Source: www.genscript.com